
Partnering with patients and families to slow progression, protect kidney health, and plan proactively for the future.
Developed by Craig G. Hurwitz, MD
If you are seeing this message, the page is still loading. The interactive education center will appear below in a moment.
Chapman AB, Devuyst O, Eckardt KU, et al. Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a KDIGO Controversies Conference. Kidney International 2015;88(1):17-27.
Torres VE, Chapman AB, Devuyst O, et al. Tolvaptan in patients with autosomal dominant polycystic kidney disease (TEMPO 3:4). New England Journal of Medicine 2012;367(25):2407-2418.
